Keyphrases
Type 2 Diabetic Patients
100%
Healthy Controls
90%
Intestinal Tract
86%
Patient-controlled
75%
Type 2 Diabetes Mellitus (T2DM)
33%
Large Intestine
33%
Expression Profile
31%
Intestine
31%
Small Intestine
30%
Enteroendocrine Cells
29%
Obesity
26%
Engineered Organoids
25%
Bile Acid Receptor
25%
Bile Acid Transporters
25%
Organic Anion Transporter
25%
Neurotensin
25%
2 Receptor
25%
Genetic Engineering
25%
Growth Hormone Secretagogue Receptor (GHS-R)
25%
Obesity Management
25%
Protease
25%
Liver-expressed Antimicrobial Peptide 2
25%
Hepatic Expression
25%
Secretin
25%
Prohormone Processing
25%
Glucagon-like
25%
Cholecystokinin
25%
Ghrelin
25%
Organoid Models
25%
Messenger RNA Expression
23%
MRNA Expression
21%
Apical Sodium-dependent Bile Acid Transporter
20%
Messenger RNA (mRNA)
19%
Duodenum
18%
Fibroblast Growth Factor 19 (FGF19)
16%
Farnesoid X Receptor
16%
SCell
15%
Liver
14%
Cell Density
13%
Intestinal mucosa
13%
N-cell
10%
Expression Pattern
8%
FGF Receptor
8%
Well-defined
7%
Human Gut
6%
Type 2 Diabetes Pathophysiology
6%
Food Intake
6%
Double-balloon Enteroscopy
6%
Ileum
6%
RNA Sequencing (RNA-seq)
6%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
90%
Receptor
50%
Large Intestine
28%
Small Intestine
26%
Glucagon Like Peptide 2
25%
Glucagon Like Peptide 2 Receptor
25%
Hepcidin
25%
Ghrelin Receptor
25%
Ghrelin
25%
Cholecystokinin
25%
Secretin
25%
Neurotensin
25%
Gut
20%
Duodenum
13%
Cell Density
13%
Food Intake
12%
Patient with Type 2 Diabetes
12%
Biopsy
11%
Pathophysiology
9%
Glucagon Like Peptide 1
8%
RNA Sequence
6%
Ileum
6%
Double-Balloon Enteroscopy
6%
Liver Biopsy
6%
Neurotensin Receptor
6%
Intestine
6%
